Dr Christopher John Mastino, MD in Fairfield, CT - Medicare Physical Medicine And Rehabilitation

Dr Christopher John Mastino, MD is a medicare enrolled "Specialist" physician in Fairfield, Connecticut. He went to Icahn School Of Medicine At Mount Sinai and graduated in 1994 and has 30 years of diverse experience with area of expertise as Physical Medicine And Rehabilitation. His current practice location is 314 Riverside Drive, Fairfield, Connecticut. You can reach out to his office (for appointments etc.) via phone at (203) 685-6326.

Dr Christopher John Mastino is licensed to practice in Connecticut (license number 037809) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1740230358.

Contact Information

	Dr Christopher John Mastino, MD
	314 Riverside Drive, Fairfield, CT 06824
	(203) 685-6326
	(203) 580-3366

Physician's Profile

Full Name	Dr Christopher John Mastino
Gender	Male
Speciality	Physical Medicine And Rehabilitation
Experience	30 Years
Location	314 Riverside Drive, Fairfield, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Christopher John Mastino attended and graduated from Icahn School Of Medicine At Mount Sinai in 1994

NPI Data:

NPI Number: 1740230358
Provider Enumeration Date: 05/12/2006
Last Update Date: 08/06/2018

Medicare PECOS Information:

PECOS PAC ID: 0749293728
Enrollment ID: I20060714000189

Medical Identifiers

Medical identifiers for Dr Christopher John Mastino such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740230358	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208100000X	Physical Medicine & Rehabilitation	037809 (Connecticut)	Secondary
174400000X	Specialist	037809 (Connecticut)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Christopher John Mastino allows following entities to bill medicare on his behalf.

Entity Name	Christopher J. Mastino Md Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1487899944 PECOS PAC ID: 0042371866 Enrollment ID: O20081211000226

News Archive

Woman's immune system behaves differently between first and later pregnancies

Among the holy quests of serious and mysterious medical challenges that doctors and research scientists strive to vanquish is preventing miscarriages, stillbirth and other pregnancy complications including preterm births.

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

An international team of researchers led by Huntsman Cancer Institute at the University of Utah has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease.

Prediction models may effectively identify erectile function after prostate cancer surgery

The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the September 21 issue of JAMA.

Barr Pharmaceuticals confirms Eloxatin injectable patent challenge

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, has initiated a challenge of the patents listed by Sanofi-Aventis U.S. LLC in connection with its Eloxatin(R) (Oxaliplatin Aqueous Solution), 5mg/mL Injectable.

Ensign subsidiary acquires Horizon Home Health and Hospice

The Ensign Group, Inc., announced today that an Ensign subsidiary acquired the operating assets of Horizon Home Health and Hospice, a well-regarded home health and hospice agency based in Meridian, Idaho. The Horizon purchase was effective May 1, 2010.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Christopher John Mastino is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Christopher John Mastino, MD 314 Riverside Drive, Fairfield, CT 06824 Ph: (203) 685-6326	Dr Christopher John Mastino, MD 314 Riverside Drive, Fairfield, CT 06824 Ph: (203) 685-6326

News Archive

Dr Christopher John Mastino, MD - Medicare Physical Medicine And Rehabilitation in Fairfield, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Woman's immune system behaves differently between first and later pregnancies

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

Prediction models may effectively identify erectile function after prostate cancer surgery

Barr Pharmaceuticals confirms Eloxatin injectable patent challenge

Ensign subsidiary acquires Horizon Home Health and Hospice

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Woman's immune system behaves differently between first and later pregnancies

Novel personalized medicine tool for assessing inherited colorectal cancer syndrome risk developed

Prediction models may effectively identify erectile function after prostate cancer surgery

Barr Pharmaceuticals confirms Eloxatin injectable patent challenge

Ensign subsidiary acquires Horizon Home Health and Hospice